您好,欢迎访问仪器信息网
注册
上海基免实业有限公司

关注

已关注

已认证

粉丝量 0

当前位置: 上海基免 > 生物分子 > 磷酸化乳腺癌抗雌激素耐药蛋白1抗体

磷酸化乳腺癌抗雌激素耐药蛋白1抗体

供货周期: 7天
品牌: Abcam
型号: 0.1ml/100μg
货号:
报价: ¥1
留言咨询
产品介绍
磷酸化乳腺癌抗雌激素耐药蛋白1抗体英文名称  Anti-phospho-BCAR1(Tyr410) 
中文名称  磷酸化乳腺癌抗雌激素耐药蛋白1抗体 
别    名  BCAR1 (phospho Y410); BCAR1(phospho Y410); p-BCAR1(p-Tyr410); Breast cancer anti estrogen resistance 1 protein; BCAR 1; Bcar1; BCAR1_HUMAN; Breast cancer anti estrogen resistance 1; Breast cancer anti-estrogen resistance protein 1; CAS; Cas scaffolding protein family member 1; Crk associated substrate; Crk associated substrate p130Cas; CRK-associated substrate; CRKAS; P130CAS. 
浓    度  1mg/1ml 
规 格  0.1ml/100μg    
公司专售磷酸化乳腺癌抗雌激素耐药蛋白1抗体、肿瘤抑制/凋亡抗体、信号分子抗体、结构蛋白抗体、磷酸化特异抗体、融合蛋白tag抗体、非哺乳动物蛋白抗体、细胞周期蛋白抗体、转录调节蛋白抗体、类固醇受体抗体、膜受体抗体、亚细胞标记抗体、同源结构域蛋白抗体、运输蛋白抗体、生长因子和激素抗体、神经生物抗体、激酶和磷酸化抗体、GDP/GTP结合蛋白抗体、合成降解蛋白抗体、离子通道抗体、淋巴细胞信号抗体、细胞粘附因子抗体、流式抗体等抗体种类,价格合理,品质有保障!      
抗体来源  Rabbit  
克隆类型  polyclonal 
交叉反应  Human, Mouse, Rat, Horse   
产品类型  一抗  磷酸化抗体   
研究领域  肿瘤 信号转导 激酶和磷酸酶  
蛋白分子量  predicted molecular weight: 93kDa 
性    状  Lyophilized or Liquid 
免 疫 原  KLH conjugated Synthesised phosphopeptide derived from human BCAR1 around the phosphorylation site of Tyr410. 
亚    型  IgG 
纯化方法  affinity purified by Protein A 
储 存 液  Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4 
产品应用   WB=1:100-500  ELISA=1:500-1000  IP=1:20-100  IHC-P=1:100-500  IHC-F=1:100-500  IF=1:100-500 
(石蜡切片需做抗原修复) 
 not yet tested in other applications.
 optimal dilutions/concentrations should be determined by the end user.  
保存条件  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 
Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 
磷酸化乳腺癌抗雌激素耐药蛋白1抗体产品介绍 p130 represents one of several known substrates for v-Crk encoded p47. p130 Cas (for Crk-associated substrate) exhibits a high level of tyrosine phosphorylation and is tightly associated with v-Crk, suggesting a role in v-Crk-mediated cell signaling. The molecular cloning of p130 Cas has shown it to represent a novel SH3 containing signaling molecule with a cluster of multiple putative SH2-binding motifs for v-Crk. By immunoprecipitation analysis, p130 Cas has been shown to be highly phosphorylated at tyrosine residues subsequent to either v-Src p60 or v-Crk-mediated transformation and to form stable complexes with both of these transforming proteins. p130 Cas behaves as an extremely potent substrate for protein tyrosine kinases and has been reported to relocate from the cytoplasm to cell membrane upon tyrosine phosphorylation. One proposed model is that the SH2 domain of v-Crk functions to activate c-Src kinase, which in turn phosphorylates p130 Cas.
Function : Docking protein which plays a central coordinating role for tyrosine kinase-based signaling related to cell adhesion. Implicated in induction of cell migration. Overexpression confers antiestrogen resistance on breast cancer cells. 
Subunit : Forms complexes in vivo with PTK2/FAK1, adapter protein CRKL and LYN kinase. Can heterodimerize with NEDD9. Interacts with BCAR3, NPHP1 and SH2D3C (By similarity). Interacts with activated CSPG4. Interacts with BMX, INPPL1/SHIP2 and PEAK1. Part of a collagen-stimulated complex involved in cell migration made of CDC42, CRK, TNK2 and BCAR1/p130cas. Interacts with TNK2 via SH3 domains. Interacts with PTK2B/PYK2.
Subcellular Location : Cell junction, focal adhesion. Cytoplasm. Note=Unphosphorylated form localizes in the cytoplasm and can move to the membrane upon tyrosine phosphorylation 
Tissue Specificity : Widely expressed with an abundant expression in the testis. Low level of expression seen in the liver, thymus, and peripheral blood leukocytes. The protein has been detected in a B-cell line.
Post-translational modifications : PTK2/FAK1 activation mediates phosphorylation at the YDYVHL motif; phosphorylation is most likely catalyzed by SRC family members. SRC-family kinases are recruited to the phosphorylated sites and can phosphorylate other tyrosine residues. Tyrosine phosphorylation is triggered by integrin-mediated adhesion of cells to the extracellular matrix.
Similarity : Belongs to the CAS family. 
Contains 1 SH3 domain. 
在纯化抗体时需要控制好几个指标,包括纯度、含量及抗体的抗原结合活性。
纯度:在实验的任何阶段,确定抗体溶液纯度的最简单方法是取一部分样本进行SDS-PAGE电泳。凝胶可用考马斯亮蓝染色(灵敏度为0.1—0.5ug/带)或银染(灵敏度1~l0ug/带)。 
定量:如果抗体还不纯,有一个快捷的定量方法,即通过SDS-PAGE电泳分离出轻、重链,然后和已知的标准染色带比较。如果需要分析许多样本,用免疫测定法对抗体定量较容易。如果抗体是经过纯化的,可通过测蛋白总量代替上述两种方法,有一简单的方法,即紫外吸收法。磷酸化乳腺癌抗雌激素耐药蛋白1抗体的量可通过测280nm处的吸收值来测(10D大致相当于0.75mg/m1的纯化抗体)。
抗原结合活性:一般说来,纯化方法不会引起抗原结合活性的改变。用蛋白G或蛋白A树脂很少导致抗体活性丧失。然而,如果最终抗体产物的作用不如原来所预料的好,检测抗体纯化过程所丢失的活性就极为重要。用一系列滴定法比较纯化的抗体和其原材料的活性,以标定每一步中的总抗体量,这将有助于较好的估计通过纯化所丢失的活性。
工商信息

企业名称

上海基免实业有限公司

企业信息已认证

企业类型

信用代码

310116002801941

成立日期

2013-03-11

注册资本

10

经营范围

联系方式
磷酸化乳腺癌抗雌激素耐药蛋白1抗体由上海基免实业有限公司为您提供,货号,规格:0.1ml/100μg,CAS号:,如您想了解更多关于磷酸化乳腺癌抗雌激素耐药蛋白1抗体价格、磷酸化乳腺癌抗雌激素耐药蛋白1抗体结构式、批发、用途等信息,欢迎咨询。除供应磷酸化乳腺癌抗雌激素耐药蛋白1抗体外,还可为您提供黄曲霉毒素B1(AFB1)检测试剂盒、植物B-葡萄糖苷酸梅(gus)检测试剂盒、马驽巴贝斯虫(babesiosis)检测试剂盒等试剂,公司有专业的客户服务团队,是您值得信赖的合作伙伴,上海基免客户服务电话,售前、售后均可联系。
推荐产品
供应产品
相关品类

上海基免实业有限公司

沟通底价

提交后,商家将派代表为您专人服务

获取验证码

{{maxedution}}s后重新发送

获取多家报价,选型效率提升30%
提交留言
点击提交代表您同意 《用户服务协议》 《隐私政策》 且同意关注厂商展位
联系方式:

公司名称: 上海基免实业有限公司

公司地址: 上海市金山工业区亭卫公路6558号9幢2441室 联系人: 肖菊芳 邮编: 201507

仪器信息网APP

展位手机站